Clinical Trial Update: Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is planned to compare a proton pump inhibitor–based triple therapy with a vonoprazan-based triple therapy (with or without zinc) for er…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Proton Pump Inhibitor (PPI)–based therapy
• Vonoprazan (vonoprazan)
• Zinc supplement (zinc)

Snippet

Sponsor: Tanta University | Conditions: HELICOBACTER PYLORI INFECTIONS | Phase 3 | Status: NOT_YET_RECRUITING